About Us > Mark Robson, MD

Mark Robson, MD

Placeholder silhouette

Highlights

  • Board-certified medical oncologist
  • Director of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center
featured_paragraph

Mark Robson, MD, is a board-certified medical oncologist and director of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center, where he specializes in the care of people with an inherited increased risk of developing cancer.

general_content

Dr. Robson helps people diagnosed with cancer use genetic information to guide their treatment decisions, and those who are at increased risk but are undiagnosed take preventive action. His research focuses on how to use genetic information to improve cancer care for people at high risk for hereditary cancers.

As an oncologist, Dr. Robson specializes in the care of young women and young women with hereditary cancers. He also coordinates screening for BRCA1 and BRCA2 gene mutations.

contributions_carousel

Contributions

Genetics and family risk

10/07/19 | BY: Mark Robson

According to the National Cancer Institute, 1 in 8 American women will develop breast cancer in her lifetime. Certain genes, small pieces of your DNA, can cause breast cancer to grow when they have a mutation, or error.

Read More
 | 8 Min. Read |

Signs breast cancer may be BRCA-related

08/20/19 | BY: Mark Robson

Certain patterns in your family’s health history may suggest that you or your relatives carry a gene mutation linked to breast cancer.

Read More
 | 7 Min. Read |

Genetic counseling

08/31/15 | BY: Jennifer Ivanovich, Rebecca Mueller, Bert Petersen, Mark Robson

Genetic counseling is the process of meeting with a genetic counselor to discuss your family health history and whether genetic testing is right for you. A genetic counselor is a Healthcare Provider.

Read More
 | 7 Min. Read

Genetic test results and treatment decisions

08/31/15 | BY: Mark Robson

Genetic testing results, whether for newly diagnosed or post-treatment individuals, can shape present and future treatment choices. Positive, negative, or uncertain results each influence decision-making uniquely.

Read More
 | 7 Min. Read

Genetic testing

08/31/15 | BY: Mark Robson

Genetic testing post-breast cancer diagnosis aids treatment decisions and risk assessment. Even after treatment, many opt for testing to gauge susceptibility to secondary breast or ovarian cancer.

Read More
 | 8 Min. Read |

Genetic testing and your relationships

08/31/15 | BY: Jennifer Ivanovich, Rebecca Mueller, Bert Petersen, Mark Robson

Taking the first step to see a genetic counselor or moving forward with genetic testing may leave you feeling everything from empowered to anxious.

Read More
 | 7 Min. Read

Genetic test results and what they mean

08/31/15 | BY: Mark Robson, A. Jo Chien

Test results indicate whether you carry a gene mutation (positive), no mutation detected (negative), or a variant of uncertain significance—a gene change with unclear cancer risk implications.

Read More
 | 6 Min. Read |

Sharing your genetic test results at work

08/31/15 | BY: Jennifer Ivanovich, Rebecca Mueller, Bert Petersen, Mark Robson

Genetic testing may require time off like a doctor's appointment. You're not obligated to disclose results or process to employers. It's personal.

Read More
 | 4 Min. Read

Sharing your genetic test results with family

08/31/15 | BY: Jennifer Ivanovich, Rebecca Mueller, Bert Petersen, Mark Robson

Genetic testing results are deeply personal, yet sharing with family may be crucial. While daunting, communication can alleviate stress and share burdens.

Read More
 | 7 Min. Read